VRDN — Viridian Therapeutics, Inc.\DE
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1590750 ·
Last close
$17.00
Market Cap
$1.88B
52W High
$30.79
52W Low
$13.18
ADV30
2,950,005
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 141,000 | — | -116,169,000 | -104,901,000 | 789,017,000 | 176,346,000 | 153,009,000 |
| Dec 2025 | 132,000 | — | -122,749,000 | -120,355,000 | 899,418,000 | 212,382,000 | 177,251,000 |
| Sep 2025 | 70,570,000 | — | -40,013,000 | -34,599,000 | 577,138,000 | 169,647,000 | 74,168,000 |
| Jun 2025 | 75,000 | — | -106,767,000 | -100,735,000 | 582,324,000 | 117,324,000 | 67,155,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-276,391,000
Investing CF
$-37,563,000
Financing CF
$426,742,000
CapEx
$-495,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.29
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,338,458,000
Inventory
—
Receivables
$70,000,000
ST Investments
$662,270,000
EBIT TTM
$-337,659,000
Pretax Income TTM
$-342,601,000
Interest Exp TTM
$4,942,000
Analysts
16
Yahoo Snapshot (yfinance, live)
Total Revenue
$70,918,000
EBITDA
$-385,233,984
Free Cash Flow
$-182,550,752
Enterprise Value
$1,200,233,472
Total Cash
$762,180,992
Total Debt
$53,350,000
Shares Out
110,427,682
Trailing EPS
$-3.35
Book Value
$5.79
ROE
-58.1%
ROA
-33.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 70,849,000 | -363,395,000 | -342,601,000 | 899,418,000 | 177,251,000 | — | -276,391,000 |
| Dec 2024 | 302,000 | -299,035,000 | -269,949,000 | 742,403,000 | 70,764,000 | — | -232,319,000 |
| Dec 2023 | 314,000 | -254,450,000 | -237,734,000 | 490,424,000 | 48,402,000 | — | -184,170,000 |
| Dec 2022 | 1,772,000 | -134,304,000 | -129,874,000 | 435,091,000 | 40,027,000 | — | -93,838,000 |
TTM Snapshot
Revenues TTM
$1,561,000
NetIncome TTM
$-167,297,000
OpCashFlow TTM
$0
Assets (Latest)
$742,403,000
Forward EPS
$-2.51
Max Pain — expiry 2026-07-17
max pain strike: $15.00 · spot: $17.00 · call oi: 4,891 · put oi: 237
Expected Move to 2026-07-17:
±$5.58
(32.79%) —
implied range
$11.43 –
$22.57
· ATM straddle on $17.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $1.88B | $20.13 | — |
| HMDCF | HUTCHMED (China) Ltd | $1.86B | $2.16 | — |
| RAPP | Rapport Therapeutics, Inc. | $1.90B | $39.71 | — |
| ZYME | Zymeworks Inc. | $1.85B | $25.40 | — |
| ANIP | ANI PHARMACEUTICALS INC | $1.85B | $81.41 | — |
News headlines (Yahoo Finance, 1h cache)
Viridian Therapeutics (VRDN) Prices Upsized Concurrent Public Offerings Totaling $350M
2026-05-21 13:30 · Yahoo
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
2026-05-17 18:52 · Yahoo
Why Viridian Therapeutics (VRDN) Is Up 25.9% After Phase 3 Elegrobart Win And Fresh Fundraising
2026-05-08 08:18 · Yahoo
Earnings Update: Viridian Therapeutics, Inc. (NASDAQ:VRDN) Just Reported And Analysts Are Boosting Their Estimates
2026-05-07 19:41 · Yahoo
Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million
2026-05-07 03:13 · Yahoo
Viridian Therapeutics’ stock up 35% after Phase III TED data release
2026-05-06 12:13 · Yahoo
Viridian Therapeutics REVEAL-2 Hits Phase 3 Endpoint, Shows “IV-like” Proptosis Gains in Chronic TED
2026-05-06 08:24 · Yahoo
Viridian (VRDN) Climbs 33% on Looming Drug Commercialization
2026-05-06 01:50 · Yahoo
How This Amgen Rival, Up 33%, Plans To Shake Its Grip In Thyroid Eye Disease
2026-05-05 20:24 · Yahoo
Viridian Therapeutics Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032, Common Stock and Series B Non-Voting Convertible Preferred Stock
2026-05-05 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.